Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients

Our study shows a low rate of MBEs, deaths and no TE events when bridging MHV patients undergoing invasive, elective procedures with prophylactic doses of LMWH.